Lannet to make drugs for China's HEC Pharm; FDA releases guidance on stability testing;

> Philadelphia-based Lannett has struck a deal with HEC Pharm Group to manufacture 25 dose forms of the Chinese company's generic products. Release

> Hospira ($HSP) is voluntarily recalling one lot of dobutamine injection, USP, 250 mg, 20 mL, in single-dose fliptop vials after glass particulate was found in a discolored vial. Report

> The FDA has released new guidance about drug stability testing. Guidance

> Johnson & Johnson ($JNJ) and Bayer Healthcare have expressed their dislike of FDA plan to use administrative orders instead of formal rulemaking to regulate over-the-counter drugs. Story

And Finally... Drug shortages continue to catch the public interest, with even Reader's Digest giving its take. Story

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.